Delaware
|
81-0710585
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
100 Technology Square
Sixth Floor
Cambridge, Massachusetts
|
02139
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Large accelerated filer
|
☐ |
Accelerated filer
|
☐
|
|||
Non-accelerated filer
|
☒ |
Smaller reporting company
|
☒
|
|||
Emerging growth company
|
☒
|
Item 8. |
Exhibits.
|
Exhibit
No.
|
Description
|
|
Fourth Amended and Restated Certificate of Incorporation of the Registrant (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on June 25, 2018 (File No. 001-38537) and incorporated herein by reference)
|
||
Certificate of Change of Registered Agent and/or Registered Office of the Registrant (filed as Exhibit 3.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 5, 2020 (File No. 001-38537) and incorporated herein by
reference)
|
||
Amended and Restated By-laws (filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on June 25, 2018 (File No. 001-38537) and incorporated herein by reference)
|
||
Second Amended and Restated Investors’ Rights Agreement among the Registrant and certain of its stockholders, dated January 9, 2018 (filed as Exhibit 4.2 to the Registrant’s Registration Statement on Form S-1 filed on May 25, 2018 (File
No. 333-225213) and incorporated herein by reference)
|
||
Opinion of Goodwin Procter LLP
|
||
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
|
||
Consent of Goodwin Procter LLP (included in Exhibit 5.1)
|
||
Power of Attorney (included on signature page)
|
||
2018 Employee Stock Purchase Plan (Incorporated by reference to Exhibit 10.14 to the registrant’s Registration Statement on Form S-1, as amended (File No. 333-225213))
|
||
Filing Fee Table
|
AVROBIO, INC.
|
||
By:
|
/s/ Geoff MacKay
|
|
Geoff MacKay
|
||
President, Chief Executive Officer and
Principal Executive Officer
|
Name
|
Title
|
Date
|
||
/s/ Geoff MacKay
|
Director, President, Chief Executive Officer and
Principal Executive Officer
|
March 23, 2023
|
||
Geoff MacKay | ||||
/s/ Erik Ostrowski
|
Chief Financial Officer and Principal Financial
and Accounting Officer
|
March 23, 2023
|
||
Erik Ostrowski | ||||
/s/ Bruce Booth
|
Chairman of the Board of Directors
|
March 23, 2023
|
||
Bruce Booth, D.Phil. | ||||
/s/ Ian T. Clark
|
Director
|
March 23, 2023
|
||
Ian T. Clark | ||||
/s/ Phillip B. Donenberg
|
Director
|
March 23, 2023
|
||
Phillip B. Donenberg | ||||
/s/ Gail M. Farfel
|
Director
|
March 23, 2023
|
||
Gail M. Farfel, Ph.D.
|
||||
/s/ Annalisa Jenkins
|
Director
|
March 23, 2023
|
||
Annalisa Jenkins, M.B.B.S., F.R.C.P. | ||||
/s/ Christopher Paige
|
Director
|
March 23, 2023
|
||
Christopher Paige, Ph.D. | ||||
/s/ Philip Vickers
|
Director
|
March 23, 2023
|
||
Philip Vickers, Ph.D. |
Very truly yours,
|
|
/s/ GOODWIN PROCTER LLP
|
|
GOODWIN PROCTER LLP
|
Security Type
|
Security Class Title
|
Fee
Calculation
Rule
|
Amount
Registered(1)
|
Proposed
Maximum
Offering
Price Per
Unit
|
Maximum
Aggregate
Offering
Price
|
Fee
Rate
|
Amount of
Registration
Fee
|
|||||||||||||||
Equity
|
Common stock, par value $0.0001 per share
|
Rule 457(c) and Rule 457(h)
|
439,161
|
(2)
|
$
|
1.05
|
(3)
|
$
|
461,119.05
|
0.00011020
|
$
|
50.82
|
||||||||||
Total Offering Amounts
|
$
|
461,119.05
|
$
|
50.82
|
||||||||||||||||||
Total Fee Offsets
|
-
|
|||||||||||||||||||||
Net Fee Due
|
$
|
50.82
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of
common stock which become issuable by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the registrant’s outstanding shares of common stock.
|
(2) |
Represents an automatic increase of 439,161 shares of common stock to the number of shares available for issuance under the registrant’s 2018 Employee Stock Purchase Plan (the “ESPP”), effective January 1, 2023. Shares available for
issuance under the ESPP were previously registered on a registration statement on Forms S-8 filed with the Securities and Exchange Commission on June 21, 2018 (Registration No. 333-225788), March 25, 2019 (Registration No. 333-230494), March
16, 2020 (Registration No. 333-237203), March 18, 2021 (Registration No. 333-254466) and March 17, 2022 (Registration No. 333-263655).
|
(3) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act, and based on 85% of $1.23 per share, which represents the average of the high and low prices of the registrant’s common stock
reported on the Nasdaq Global Select Market on March 20, 2023. Pursuant to the ESPP, the purchase price of the shares of common stock reserved for issuance thereunder will be 85% of the fair market value of a share of common stock on the
first trading day of the offering period or on the exercise date, whichever is less.
|